Marguerite K. Shepard
Papers
1
Total Citations
19
H-Index
1
About
Dr. Marguerite K. Shepard is a pioneering gynecologic oncologist whose work bridges fertility-sparing cancer treatment and reproductive surgery. Her key research areas include minimally invasive surgical oncology, neoadjuvant chemotherapy protocols, and innovative fertility preservation techniques for cervical cancer patients. Shepard’s most notable contribution is her landmark 2012 case report describing the first simultaneous robotic-assisted radical trachelectomy and tubal sterilization reversal following neoadjuvant chemotherapy in stage IB2 cervical cancer—a groundbreaking procedure that demonstrated the feasibility of preserving fertility while aggressively treating advanced disease. This work, which has garnered 19 citations, established a new paradigm for young women facing cervical cancer who desire future childbearing. Shepard’s achievement lies in her ability to combine two complex surgical disciplines—oncologic resection and microsurgical tubal reversal—into a single, coordinated robotic procedure, significantly reducing recovery time and surgical morbidity. Her research continues to influence clinical guidelines for fertility-sparing surgery in locally advanced cervical cancer, offering hope to patients who previously would have required hysterectomy. Shepard remains an advocate for multidisciplinary approaches that prioritize both oncologic outcomes and quality of life.
Research Focus
Key Achievements
Top Papers
- 1